2222 1111

Global Diarrhea Vaccine Supply, Demand and Key Producers, 2026-2032

  • 出版日期 2026-05-03
  • 頁數 129 頁
  • 價格 歡迎來信或來電洽詢價格
  • 出版商 Global Info Research
  • 報告Sample索取 歡迎來信或來電直接索取sample檔案

簡介

The global Diarrhea Vaccine market size is expected to reach $ 1430 million by 2032, rising at a market growth of 2.4% CAGR during the forecast period (2026-2032).
Diarrhea vaccines generally refer to vaccines used to prevent infectious diarrhea caused by specific pathogens (such as rotavirus, norovirus, etc.). There are many types of diarrhea vaccines, mainly including EV71 vaccines, rotavirus vaccines, and cholera vaccines. The global market size is currently over $1.2 billion, with the Chinese market exceeding $400 million.
This report studies the global Diarrhea Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Diarrhea Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Diarrhea Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Diarrhea Vaccine total production and demand, 2021-2032, (K Dose)
Global Diarrhea Vaccine total production value, 2021-2032, (USD Million)
Global Diarrhea Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Diarrhea Vaccine consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Diarrhea Vaccine domestic production, consumption, key domestic manufacturers and share
Global Diarrhea Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Diarrhea Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Diarrhea Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Diarrhea Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include MSD, Sanofi, EuBiologics, Vabiotech, PaxVax, GlaxoSmithKline, Serum Institute of India, Bharat Biotech, Chinese Academy of Medical Sciences, Sinovac Biotech Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Diarrhea Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Diarrhea Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Diarrhea Vaccine Market, Segmentation by Type:
Rotavirus Vaccine
Cholera Vaccine
EV71 Vaccine
Global Diarrhea Vaccine Market, Segmentation by Application:
Newborn
Adult
Companies Profiled:
MSD
Sanofi
EuBiologics
Vabiotech
PaxVax
GlaxoSmithKline
Serum Institute of India
Bharat Biotech
Chinese Academy of Medical Sciences
Sinovac Biotech Ltd
China National Biotec Corporation
Shanghai United Cell Biotechnology
Key Questions Answered:
1. How big is the global Diarrhea Vaccine market?
2. What is the demand of the global Diarrhea Vaccine market?
3. What is the year over year growth of the global Diarrhea Vaccine market?
4. What is the production and production value of the global Diarrhea Vaccine market?
5. Who are the key producers in the global Diarrhea Vaccine market?
6. What are the growth factors driving the market demand?

目錄

1 Supply Summary
1.1 Diarrhea Vaccine Introduction
1.2 World Diarrhea Vaccine Supply & Forecast
1.2.1 World Diarrhea Vaccine Production Value (2021 & 2025 & 2032)
1.2.2 World Diarrhea Vaccine Production (2021-2032)
1.2.3 World Diarrhea Vaccine Pricing Trends (2021-2032)
1.3 World Diarrhea Vaccine Production by Region (Based on Production Site)
1.3.1 World Diarrhea Vaccine Production Value by Region (2021-2032)
1.3.2 World Diarrhea Vaccine Production by Region (2021-2032)
1.3.3 World Diarrhea Vaccine Average Price by Region (2021-2032)
1.3.4 North America Diarrhea Vaccine Production (2021-2032)
1.3.5 Europe Diarrhea Vaccine Production (2021-2032)
1.3.6 China Diarrhea Vaccine Production (2021-2032)
1.3.7 Japan Diarrhea Vaccine Production (2021-2032)
1.3.8 India Diarrhea Vaccine Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Diarrhea Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Diarrhea Vaccine Major Market Trends
2 Demand Summary
2.1 World Diarrhea Vaccine Demand (2021-2032)
2.2 World Diarrhea Vaccine Consumption by Region
2.2.1 World Diarrhea Vaccine Consumption by Region (2021-2026)
2.2.2 World Diarrhea Vaccine Consumption Forecast by Region (2027-2032)
2.3 United States Diarrhea Vaccine Consumption (2021-2032)
2.4 China Diarrhea Vaccine Consumption (2021-2032)
2.5 Europe Diarrhea Vaccine Consumption (2021-2032)
2.6 Japan Diarrhea Vaccine Consumption (2021-2032)
2.7 South Korea Diarrhea Vaccine Consumption (2021-2032)
2.8 ASEAN Diarrhea Vaccine Consumption (2021-2032)
2.9 India Diarrhea Vaccine Consumption (2021-2032)
3 World Manufacturers Competitive Analysis
3.1 World Diarrhea Vaccine Production Value by Manufacturer (2021-2026)
3.2 World Diarrhea Vaccine Production by Manufacturer (2021-2026)
3.3 World Diarrhea Vaccine Average Price by Manufacturer (2021-2026)
3.4 Diarrhea Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Diarrhea Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Diarrhea Vaccine in 2025
3.5.3 Global Concentration Ratios (CR8) for Diarrhea Vaccine in 2025
3.6 Diarrhea Vaccine Market: Overall Company Footprint Analysis
3.6.1 Diarrhea Vaccine Market: Region Footprint
3.6.2 Diarrhea Vaccine Market: Company Product Type Footprint
3.6.3 Diarrhea Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
4.1 United States VS China: Diarrhea Vaccine Production Value Comparison
4.1.1 United States VS China: Diarrhea Vaccine Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Diarrhea Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Diarrhea Vaccine Production Comparison
4.2.1 United States VS China: Diarrhea Vaccine Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Diarrhea Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Diarrhea Vaccine Consumption Comparison
4.3.1 United States VS China: Diarrhea Vaccine Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Diarrhea Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Diarrhea Vaccine Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Diarrhea Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Diarrhea Vaccine Production Value (2021-2026)
4.4.3 United States Based Manufacturers Diarrhea Vaccine Production (2021-2026)
4.5 China Based Diarrhea Vaccine Manufacturers and Market Share
4.5.1 China Based Diarrhea Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Diarrhea Vaccine Production Value (2021-2026)
4.5.3 China Based Manufacturers Diarrhea Vaccine Production (2021-2026)
4.6 Rest of World Based Diarrhea Vaccine Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Diarrhea Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Diarrhea Vaccine Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Diarrhea Vaccine Production (2021-2026)
5 Market Analysis by Type
5.1 World Diarrhea Vaccine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Rotavirus Vaccine
5.2.2 Cholera Vaccine
5.2.3 EV71 Vaccine
5.3 Market Segment by Type
5.3.1 World Diarrhea Vaccine Production by Type (2021-2032)
5.3.2 World Diarrhea Vaccine Production Value by Type (2021-2032)
5.3.3 World Diarrhea Vaccine Average Price by Type (2021-2032)
6 Market Analysis by Application
6.1 World Diarrhea Vaccine Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Newborn
6.2.2 Adult
6.3 Market Segment by Application
6.3.1 World Diarrhea Vaccine Production by Application (2021-2032)
6.3.2 World Diarrhea Vaccine Production Value by Application (2021-2032)
6.3.3 World Diarrhea Vaccine Average Price by Application (2021-2032)
7 Company Profiles
7.1 MSD
7.1.1 MSD Details
7.1.2 MSD Major Business
7.1.3 MSD Diarrhea Vaccine Product and Services
7.1.4 MSD Diarrhea Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.1.5 MSD Recent Developments/Updates
7.1.6 MSD Competitive Strengths & Weaknesses
7.2 Sanofi
7.2.1 Sanofi Details
7.2.2 Sanofi Major Business
7.2.3 Sanofi Diarrhea Vaccine Product and Services
7.2.4 Sanofi Diarrhea Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.2.5 Sanofi Recent Developments/Updates
7.2.6 Sanofi Competitive Strengths & Weaknesses
7.3 EuBiologics
7.3.1 EuBiologics Details
7.3.2 EuBiologics Major Business
7.3.3 EuBiologics Diarrhea Vaccine Product and Services
7.3.4 EuBiologics Diarrhea Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.3.5 EuBiologics Recent Developments/Updates
7.3.6 EuBiologics Competitive Strengths & Weaknesses
7.4 Vabiotech
7.4.1 Vabiotech Details
7.4.2 Vabiotech Major Business
7.4.3 Vabiotech Diarrhea Vaccine Product and Services
7.4.4 Vabiotech Diarrhea Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.4.5 Vabiotech Recent Developments/Updates
7.4.6 Vabiotech Competitive Strengths & Weaknesses
7.5 PaxVax
7.5.1 PaxVax Details
7.5.2 PaxVax Major Business
7.5.3 PaxVax Diarrhea Vaccine Product and Services
7.5.4 PaxVax Diarrhea Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.5.5 PaxVax Recent Developments/Updates
7.5.6 PaxVax Competitive Strengths & Weaknesses
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Details
7.6.2 GlaxoSmithKline Major Business
7.6.3 GlaxoSmithKline Diarrhea Vaccine Product and Services
7.6.4 GlaxoSmithKline Diarrhea Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.6.5 GlaxoSmithKline Recent Developments/Updates
7.6.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.7 Serum Institute of India
7.7.1 Serum Institute of India Details
7.7.2 Serum Institute of India Major Business
7.7.3 Serum Institute of India Diarrhea Vaccine Product and Services
7.7.4 Serum Institute of India Diarrhea Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.7.5 Serum Institute of India Recent Developments/Updates
7.7.6 Serum Institute of India Competitive Strengths & Weaknesses
7.8 Bharat Biotech
7.8.1 Bharat Biotech Details
7.8.2 Bharat Biotech Major Business
7.8.3 Bharat Biotech Diarrhea Vaccine Product and Services
7.8.4 Bharat Biotech Diarrhea Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.8.5 Bharat Biotech Recent Developments/Updates
7.8.6 Bharat Biotech Competitive Strengths & Weaknesses
7.9 Chinese Academy of Medical Sciences
7.9.1 Chinese Academy of Medical Sciences Details
7.9.2 Chinese Academy of Medical Sciences Major Business
7.9.3 Chinese Academy of Medical Sciences Diarrhea Vaccine Product and Services
7.9.4 Chinese Academy of Medical Sciences Diarrhea Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.9.5 Chinese Academy of Medical Sciences Recent Developments/Updates
7.9.6 Chinese Academy of Medical Sciences Competitive Strengths & Weaknesses
7.10 Sinovac Biotech Ltd
7.10.1 Sinovac Biotech Ltd Details
7.10.2 Sinovac Biotech Ltd Major Business
7.10.3 Sinovac Biotech Ltd Diarrhea Vaccine Product and Services
7.10.4 Sinovac Biotech Ltd Diarrhea Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.10.5 Sinovac Biotech Ltd Recent Developments/Updates
7.10.6 Sinovac Biotech Ltd Competitive Strengths & Weaknesses
7.11 China National Biotec Corporation
7.11.1 China National Biotec Corporation Details
7.11.2 China National Biotec Corporation Major Business
7.11.3 China National Biotec Corporation Diarrhea Vaccine Product and Services
7.11.4 China National Biotec Corporation Diarrhea Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.11.5 China National Biotec Corporation Recent Developments/Updates
7.11.6 China National Biotec Corporation Competitive Strengths & Weaknesses
7.12 Shanghai United Cell Biotechnology
7.12.1 Shanghai United Cell Biotechnology Details
7.12.2 Shanghai United Cell Biotechnology Major Business
7.12.3 Shanghai United Cell Biotechnology Diarrhea Vaccine Product and Services
7.12.4 Shanghai United Cell Biotechnology Diarrhea Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.12.5 Shanghai United Cell Biotechnology Recent Developments/Updates
7.12.6 Shanghai United Cell Biotechnology Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Diarrhea Vaccine Industry Chain
8.2 Diarrhea Vaccine Upstream Analysis
8.2.1 Diarrhea Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Diarrhea Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Diarrhea Vaccine Production Mode
8.6 Diarrhea Vaccine Procurement Model
8.7 Diarrhea Vaccine Industry Sales Model and Sales Channels
8.7.1 Diarrhea Vaccine Sales Model
8.7.2 Diarrhea Vaccine Typical Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

關鍵字

  • Pharma & Healthcare